FDA inspection
Octapharma Produktionsgesellschaft Deutschland mbH: FDA inspection ending Jun 11, 2024
FDA inspection 1240862 · Voluntary Action Indicated (VAI) · Springe
Key facts
| Inspection ID | 1240862 |
|---|---|
| Firm | Octapharma Produktionsgesellschaft Deutschland mbH |
| FEI number | 3016855360 |
| Address | Wolfgang-Marguerre-Allee 1 |
| City | Springe |
| Country | Germany |
| Fiscal year | 2024 |
| Inspection end date | Jun 11, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data